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Abstract
Aim
We examined whether glycated haemoglobin (HbA1c) is associated to carotid atherosclero-
sis in an elderly Korean population with normal fasting glucose.
Methods
Using data from the Korean Urban Rural Elderly study, we conducted a cross-sectional
analysis of 1,133 participants (335 men and 798 women) with a mean age of 71.8 years. All
participants had fasting blood glucose less than 100mg/dL (5.6 mmol/L) and HbA1c level
below 6.5% (48 mmol/mol). They were also free from a history of cardiovascular disease,
known type 2 diabetes mellitus or use of anti-diabetes medications. Carotid atherosclerosis
was assessed by intima-media thickness (IMT) using ultrasonography. The association
between HbA1c and carotid IMT was investigated using multivariable linear regression
analysis.
Results
HbA1c levels were independently and positively associated with carotid IMT (β = 0.020, p =
0.045) after adjusting for sex, age, body mass index, systolic blood pressure, diastolic blood
pressure, triglyceride, LDL cholesterol, smoking and alcohol intake. However, fasting insulin
and glucose levels were not associated with carotid IMT.
Conclusion
HbA1c levels were positively associated with carotid atherosclerosis, as assessed by
carotid IMT, in an elderly population with normoglycemia. Our study suggested that higher
HbA1c level is an effective and informative marker of carotid atherosclerosis in an elderly
population.
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Introduction
Glycated hemoglobin (HbA1c) is an well-known indicator used to assess long-term control of
diabetes, and HbA1c level has been used as a diagnostic or screening tool for type 2 diabetes mel-
litus[1]. Previous studies showed positive associations of HbA1c levels with cardiovascular dis-
ease and mortality in those with diabetes mellitus[2–5]. Microvascular complications, such as
nephropathy and retinopathy, are also associated with HbA1c[6]. Studies also observed a rela-
tionship between HbA1c and atherosclerosis among people with and without diabetes[7–9].
Carotid intima-media thickness (IMT) is known as a highly reproducible and non-invasive
method to access atherosclerotic process[10–12]. Increased carotid IMT is also a predictor of ath-
erosclerotic cardiovascular disease such as stroke and myocardial infarction[13–16]. Previous
intervention studies reported that there were reductions of carotid IMT in patients with lipid-
lowering drugs compared with a placebo group[17,18]. In people with diagnosed and unrecog-
nized diabetes, HbA1c was independently related to carotid IMT[9]. Interestingly, HbA1c levels
were positively associated with carotid IMT in the people with normoglycemia as well[7,8]. How-
ever, the association was not clear in the Asian population[7,8]. In an elderly Asian population
with normal fasting glucose levels, the association between HbA1c and subclinical carotid athero-
sclerosis has not been fully investigated. Thus, in the current study, we evaluated the association
between HbA1c and carotid IMT in an elderly Korean population with normal fasting glucose.
Materials and methods
Study population
This study analyzed baseline data in 2012 and 2013 from the Korean Urban Rural Elderly
(KURE) study which is a community-based cohort study. The procedures of data collection in
KURE have been described elsewhere in detail [19,20]. During the summers (June to Septem-
ber) of 2012 and 2013, a total of 2,025 participants aged more than 65 years were enrolled from
urban and rural communities. All participants conducted questionnaire interview and health
examination as a prescribed protocol. Among the 2,025 participants, based on the results of
physical examination, people who had a fasting glucose level< 100 mg/dL (5.6 mmol/L) and
an HbA1c level< 6.5% (48 mmol/mol) were included in the current analysis. Those with a his-
tory of major cardiovascular disease such as myocardial infarction or stroke (n = 273) or who
were under treatment for diabetes (n = 349) were excluded from the current analysis. People
who had missing important covariate data (n = 5) were also excluded. Finally, a total of 1,133
participants were included in the current analysis. All participants provided written informed
consent forms and study protocol was approved by the Institutional Review Board of Sever-
ance Hospital at Yonsei University College of Medicine (approval number: 4-2012-0172;
approval date: May 3, 2012). at the beginning of the study.
Questionnaire data
The KURE study collected information on demographics, medical history, and lifestyle using
standardized questionnaires. All interviewers were trained and performed the questionnaire
surveys according to the prescribed procedure. Smoking status of participants was categorized
as current smokers or current nonsmokers. Alcohol intake was classified in the current study
as regular alcohol consumption (once a week or more) or other (less than once a week).
Physical examination
The methods for physical examination in the KURE were previously reported in detail else-
where[19,21,22]. All participants wore identical hospital gown for physical examination. A
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trained research examiner made anthropometric measurements including standing height
(cm), body weight (kg) and waist circumferences as described previously and body mass index
(BMI) was calculated [23]. Resting systolic and diastolic blood pressures (SBP and DBP) were
measured more than twice using automatic sphygmomanometer (Omron HEM-7111, Omron
Healthcare, Kyoto, Japan). Prior to each measurement, participants had rested for at least five
minutes in sitting position. If the first and second measurements differ by 10 mmHg for
either SBP or DBP, an additional measurement was performed, and the average of the last two
measurements was used for analysis. Carotid IMT were measured by high-resolution B-mode
ultrasonography using an 8-MHz linear probe (L5-13IS, Samsung Medicine, Seoul, Korea) in
both carotid arteries. Both left and right carotid arteries were examined at levels of the distal
common carotid artery, 1.0 cm proximal to the carotid bulb, and the proximal internal carotid
artery in both transverse and longitudinal orientations by an single technician as a prescribed
protocol[24]. The IMT was defined as the distance between the adventitia-media interface and
intima-lumen interface[19]. IMT measurements were performed at all three segments provid-
ing a total of 6 measurements per person. The maximum value of the 6 measurements from
the bilateral IMTs was used in the analysis. All scans were digitally stored for subsequent off-
line analysis. One end-diastolic frame (captured adjacent to the R wave on a continuously
recorded ECG) for each interrogation angle was selected and analyzed for mean and maxi-
mum IMT. Carotid IMT was analyzed as markers of carotid atherosclerosis. We reported
previously that inter-rater reliability of carotid IMT in our clinical centers. The inter-rater reli-
ability of carotid IMT measurements among three clinical centers turned out to be high (calcu-
lated intraclass correlation coefficient 0.647 [95% CI: 0.487–0.779] for maximum carotid IMT)
[25].
Laboratory assays
After at least eight hours of fast, blood samples were collected from the antecubital vein in the
morning. Fasting blood glucose level was determined by a colorimetry method (ADVIA 1800,
Siemens, USA). Insulin level was measured by a chemiluminescence immunoassay (Centaur
XP, Siemens, USA). Homeostasis model assessment of insulin resistance (HOMA-IR) was
used to evaluate insulin resistance: HOMA-IR = fasting plasma glucose (mg/dL) × fasting insu-
lin (μIU/mL)/405[26]. An enzymatic method (ADVIA 1800, Siemens, USA) was used to assess
total cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides. C-reactive pro-
tein (CRP) concentration was assessed by a turbidometric immunoassay (ADVIA 1800, Wako,
Japan). Low-density lipoprotein (LDL) cholesterol was calculated according to the Friedewald
formula: LDL cholesterol = Total cholesterol—HDL cholesterol—(triglycerides/5) (all concen-
trations in mg/dL)[27]. HbA1c levels were measured by high-performance liquid chromatog-
raphy using the VARIANT II system (Bio-Rad, Hercules, CA, USA).
Statistical analysis
Gender differences in general characteristics were assessed by an independent t-test, Wilcoxon
rank sum test, or chi-square test. Fasting insulin, HOMA-IR and CRP levels were log-trans-
formed for parametric testing due to a right-skewed distribution. The relationships between
interesting variables and other variables were evaluated using Pearson correlation analysis
along with scatter plots.
In order to investigate an independent association between HbA1c and carotid IMT, we
used multivariable linear regression analyses. Confounders were selected based on previous
studies: sex, age, waist circumference, SBP, DBP, triglycerides, LDL cholesterol, HOMA-IR,
smoking status, and alcohol intake. We also tested for the presence of effect modification by
HbA1c and carotid atherosclerosis in normoglycemia
PLOS ONE | DOI:10.1371/journal.pone.0171761 February 8, 2017 3 / 12
sex including interaction term in separate models. All analyses were performed using SAS sta-
tistical software, version 9.4 (SAS Institute, Cary, NC, USA), and all statistical tests were two-
sided and p value less than 0.05 was considered significant.
Results
The general characteristics of the study population are shown in Table 1. In this study, a total
of 1,133 participants with a mean age of 71.8 years, consisting of 335 men and 798 women,
were included. The mean HbA1c level was 5.5% (37 mmol/mol) and mean carotid IMT was
0.9 mm. Men tended to have a higher SBP, DBP, and waist circumference. However, men also
had higher levels of HbA1c, insulin, lipid profiles, HOMA IR and CRP than women.
Table 2 shows the correlations of carotid IMT and other variables. HbA1c was significantly
and positively correlated with carotid IMT after adjusting for sex and age. Conversely, fasting
glucose and insulin levels were not associated with carotid IMT after adjusting for age. The
unadjusted association between HbA1c and carotid IMT is also showed by scatter plots, sepa-
rately for men and women (Fig 1). The positive association between HbA1c and carotid IMT
was more prominent in men than in women.
Table 3 shows the relationship between HbA1c and carotid IMT in multivariable linear
regression models. HbA1c was positively associated with carotid IMT (β = 0.026, p = 0.009).
The positive association between HbA1c and carotid IMT was not affected by adjustment for
sex, body mass index (BMI), SBP, DBP, triglyceride, LDL cholesterol, HOMA-IR, smoking,
and alcohol consumption (β = 0.020, p = 0.045). The interactions between sex and HbA1c for
carotid IMT was not significant (p = 0.3374). However, when examining this association for
Table 1. General characteristics of the study population.
Variables Total (n = 1,133) Men (n = 335) Women (n = 798) p valuea
Age, years 71.8 ± 4.8 72.7 ± 4.9 71.4 ± 4.8 < .001
BMI, kg/m2 23.8 ± 2.9 23.3 ± 2.8 24.1 ± 3.0 < .001
Waist circumference, cm 82.6 ± 8.6 84.3 ± 8.6 81.9 ± 8.5 < .001
SBP, mmHg 127.2 ± 15.2 128.6 ± 14.5 126.7 ± 15.4 0.044
DBP, mmHg 72.9 ± 8.4 73.8 ± 8.5 72.5 ± 8.4 0.015
Carotid IMT, mm 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 < .001
Fasting glucose, mg/dL 88.5 ± 6.2 88.4 ± 6.4 88.6 ± 6.1 0.646
Fasting insulin, mg/dL 5.1 [3.7–7.5] 4.3 [3.1–6.3] 5.5 [3.9–8.0] 0.007
HbA1c, % 5.5 ± 0.3 5.4 ± 0.3 5.5 ± 0.3 0.028
Total cholesterol, mg/dL 188.5 ± 34.7 178.7 ± 30.3 192.6 ± 35.7 0.292
HDL cholesterol, mg/dL 51.7 ± 12.3 48.2 ± 11.2 53.1 ± 12.4 0.003
LDL cholesterol, mg/dL 111.6 ± 30.2 106.3 ± 27.0 113.9 ± 31.3 < .001
Triglyceride, mg/dL 126.0 ± 61.1 121.3 ± 58.1 127.9 ± 62.2 < .001
HOMA-IR 1.1 [0.8–1.7] 0.9 [0.7–1.4] 1.2 [0.8–1.8] < .001
CRP, mg/L 0.7 [0.4–1.4] 0.8 [0.4–1.5] 0.7 [0.4–1.4] < .001
Smoking, current 72 (6.4) 59 (17.7) 13 (1.6) < .001
Alcohol intake, current 394 (34.8) 186 (55.7) 208 (26.1) < .001
Values are presented as mean ± standard deviation, median [interquartile range], or number (%).
aP values for comparison of gender characteristics are based independent t-test, the Wilcoxon rank sum test, or chi-square test.
P values compare men and women using independent t-test, the Wilcoxon rank sum test, or chi-square test.
Abbreviations: BMI, body mass index; CRP, C-reative protein; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-IR, homeostasis model
assessment of insulin resistance; IMT, intima-media thickness; LDL, low-density lipoprotein; SBP, systolic blood pressure
doi:10.1371/journal.pone.0171761.t001
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men and women separately, the association between HbA1c and carotid IMT was not signifi-
cant in women.
Discussion
We investigated the association between HbA1c and carotid IMT in among elderly Koreans
with a normal fasting glucose. HbA1c was positively related to carotid IMT. The association
between HbA1c and carotid IMT was significant before and after adjustment for covariates,
particularly in men. Although there are a significant relationship between HbA1c and carotid
IMT only for men in our study, there is a significant relationship between HbA1c and carotid
IMT in total population and the interaction test for sex was not significant (p = 0.3374). In our
study, carotid IMT was defined by maximum thickness value. The average thickness value was
not significantly associated with HbA1c as well as fasting glucose and insulin contrary to maxi-
mum thickness value in our study. We could not elucidate the reason, there is a possibility
linking the characteristics of study population. Our study population was relatively healthy
and without major cardiovascular disease such as myocardial infarction or stroke and diabetes
mellitus. They might be still early stages of carotid atherosclerosis.
Previous researches have investigated the association between HbA1c and atherosclerosis
assessed by carotid IMT in persons without diabetes [8,28–30]. A positive association was
reported in several cross-sectional studies on diverse ethnic groups, including American,
German, Chinese, and Asian Indians[7,8,28,31]. A consistent association was also observed in
our study participants who were elderly and non-obese. Previous studies analyzed relatively
young (40–60 years) and obese (BMI > 25 kg/m2) participants, unique from our patient pool
[7,8,28,31]. However, a previous Korean study among people without diabetes HbA1c was not
associated with carotid IMT and plaque, but HbA1c was positively associated with brachial-
Table 2. Correlation of carotid IMT with other variables.
Simple Correlation Partial Correlationa
Total (n = 1,133) Pearson coefficients p value Pearson coefficients p value
Age 0.168 < .001
BMI 0.081 0.006 0.110 < .001
Waist circumference 0.135 < .001 0.120 < .001
SBP 0.132 < .001 0.104 < .001
DBP - 0.019 0.527 - 0.011 0.711
HbA1c 0.077 0.009 0.084 0.005
Fasting glucose - 0.014 0.644 - 0.015 0.623
Fasting insulin (logarithmic) - 0.007 0.820 0.019 0.514
Total cholesterol 0.053 0.075 0.081 0.006
HDL cholesterol - 0.123 < .001 - 0.105 < .001
LDL cholesterol 0.080 0.007 0.102 < .001
Triglycerides 0.076 0.011 0.079 0.008
HOMA-IR (logarithmic) - 0.008 0.794 0.017 0.561
CRP (logarithmic) 0.058 0.049 0.049 0.098
Smoking 0.037 0.208 < .001 0.996
Alcohol intake - 0.002 0.930 - 0.018 0.541
aPartial correlation analysis with adjustment for sex and age.
Abbreviations: BMI, body mass index; CRP, C-reative protein; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-IR, homeostasis model
assessment of insulin resistance; IMT, intima-media thickness; LDL, low-density lipoprotein; SBP, systolic blood pressure.
doi:10.1371/journal.pone.0171761.t002
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ankle pulse wave velocity[32]. A previous prospective study also reported that HbA1c was not
related to carotid atherosclerosis[29]. This study included people with a < 110 mg/dL (6.1
mmol/L) fasting glucose level, whereas our study included people with fasting blood glucose
less than 100 mg/dL (5.6 mmol/L) and HbA1c level below 6.5% (48 mmol/mol). According to
our analyses, fasting glucose and insulin were not associated with carotid IMT in elderly popu-
lation with normal fasting glucose. This finding may be attributed to the characteristics of our
study subjects, whose average HOMA-IR was 1.1 [0.8–1.7], indicating a highly insulin sensitive
condition. This value was much lower than that reported by Venkataraman et al. (HOMA-IR
of 1.4 to 1.9)[28], despite a similar BMI distribution. In a previous study with 582 individuals
aged 40–70 years without known diabetes, post-challenge plasma glucose presented a strong
association with atherosclerosis, but fasting glucose and HbA1c levels did not have a signifi-
cant association with atherosclerosis[30]. On the other hand, HbA1c had positive and signifi-
cant associations with carotid IMT in our study. In a previous Korean study of diabetic
patients, HbA1c was positively related to carotid plaques, but not with carotid IMT[33]. This
previous study examined association between HbA1c, carotid atherosclerosis, arterial stiffness,
and peripheral arterial disease among Korean patients with type 2 diabetes (n = 370) registered
with the public health center. But we examined HbA1c and carotid IMT using a larger sample
with relatively healthy community dweller.
Recent studies have shown that hyperglycemia may lead to arteriopathy by inducing oxida-
tive stress, which facilitate the formation of advanced glycosylation end products[34]. Glycosyl-
ation end products are associated with glycation and susceptibility to LDL oxidation and
subsequent uptake by macrophages, thereby creating foam cells[35], which is associated with
atherosclerosis initiation. Macrophages are important factors in all atherosclerotic stages[36]. In
diabetic patients, approximately 80% of deaths is caused by atherosclerosis[34]. Hyperglycemia
Fig 1. Pearson correlation coefficient and p value between carotid IMT and HbA1c.
doi:10.1371/journal.pone.0171761.g001
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Table 3. Association between HbA1c and carotid IMT.
Unadjusted Adjusteda
β SE R2 p value β SE p value
Total (n = 1,133)
Sex, male - 0.027 0.007 0.013 < .001 - 0.031 0.008 < .001
Age, 10 years 0.038 0.007 0.028 < .001 0.025 0.007 < .001
BMI, kg/m2 0.003 0.001 0.007 0.006 0.005 0.001 < .001
HbA1c, % 0.026 0.010 0.006 0.009 0.020 0.010 0.045
SBP, 10 mmHg 0.009 0.002 0.018 < .001 0.017 0.003 < .001
DBP, 5 mmHg - 0.001 0.002 < .001 0.527 - 0.013 0.003 < .001
Triglyceride, g/dL 0.135 0.053 0.006 0.011 0.113 0.054 0.035
LDL cholesterol, g/dL 0.289 0.107 0.006 0.007 0.345 0.104 0.001
HOMA-IR (logarithmic) < .001 0.006 < .001 0.955 - 0.007 0.006 0.093
CRP, mg/L (logarithmic) 0.006 0.003 0.003 0.049 0.002 0.003 0.463
Current smoking - 0.019 0.006 0.010 0.001 < .001 0.014 0.979
Current drinking - 0.001 0.007 < .001 0.930 - 0.003 0.007 0.711
Adjusted R2 = 0.0868
Men (n = 335)
Age, 10 years 0.045 0.012 0.041 < .001 0.041 0.013 0.002
BMI, kg/m2 0.004 0.002 0.010 0.065 0.006 0.003 0.008
HbA1c, % 0.044 0.017 0.019 0.012 0.036 0.017 0.040
SBP, 10 mmHg 0.004 0.004 0.002 0.371 0.010 0.005 0.076
DBP, 5 mmHg - 0.007 0.004 0.012 0.049 - 0.011 0.005 0.023
Triglyceride, g/dL 0.128 0.104 0.005 0.217 0.095 0.108 0.372
LDL cholesterol, g/dL 0.170 0.224 0.002 0.449 0.149 0.220 0.497
HOMA-IR (logarithmic) - 0.002 0.010 < .001 0.814 - 0.016 0.012 0.070
CRP, mg/L (logarithmic) 0.002 0.006 < .001 0.765 -0.001 0.006 0.861
Current smoking - 0.005 0.016 < .001 0.756 -0.005 0.016 0.753
Current drinking - 0.029 0.012 0.017 0.018 -0.020 0.012 0.094
Adjusted R2 = 0.0797
Women (n = 798)
Age, 10 years 0.030 0.008 0.018 < .001 0.016 0.008 0.048
BMI, kg/m2 0.003 0.001 0.009 0.008 0.004 0.001 0.002
HbA1c, % 0.023 0.012 0.005 0.058 0.013 0.012 0.303
SBP, 10 mmHg 0.011 0.002 0.025 < .001 0.020 0.004 < .001
DBP, 5 mmHg 0.001 0.002 < .001 0.821 - 0.014 0.003 < .001
Triglyceride, g/dL 0.152 0.061 0.008 0.013 0.120 0.062 0.051
LDL cholesterol, g/dL 0.392 0.121 0.013 0.001 0.406 0.118 0.001
HOMA-IR (logarithmic) 0.003 0.007 0.001 0.447 - 0.004 0.008 0.408
CRP, mg/L (logarithmic) 0.008 0.004 0.005 0.049 0.005 0.004 0.215
Current smoking 0.026 0.030 0.001 0.381 0.032 0.029 0.277
Current drinking 0.002 0.009 < .001 0.815 0.008 0.008 0.370
Adjusted R2 = 0.0771
aAdjusted for other variables in the table.
Abbreviations: BMI, body mass index; CRP, C-reative protein; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment of insulin
resistance; IMT, intima-media thickness; LDL, low-density lipoprotein; SBP, systolic blood pressure; SE, standard error.
doi:10.1371/journal.pone.0171761.t003
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is a well-known pathogenic factor of atherosclerosis as it leads to alteration of vascular tissue at
the cellular level and consequent atherosclerotic disease[34]. In diabetes, these alterations are
caused by nonenzymatic glycosylation of proteins and lipids. This glycosylation can cause dys-
function of protein and lipid by obstructing enzymatic activity and receptor recognition[37].
Furthermore, glycosylated proteins were associated with a specific receptor of cells related to
the atherosclerotic process such as monocyte-derived macrophages, endothelial cells, and
smooth muscle cells. Their interaction can increase production of oxidative stress and proin-
flammatory responses that promote the atherosclerotic process[34].
The mechanism linking HbA1c and carotid atherosclerosis has still not been fully eluci-
dated. However, some potential mechanisms that may be responsible for these associations
have been suggested. People who had a relatively higher level of fasting glucose within the nor-
mal range may have higher postprandial glucose levels, which may be reflected by HbA1c[38].
Furthermore, postprandial glucose levels are more closely associated with increased carotid
atherosclerosis[39,40]. Moreover, even among people with normal fasting glucose, people who
had a glycometabolism disorder were at risk for increased carotid atherosclerosis[41,42].
Although we could not verify this possibility because we did not measure post-prandial glucose
levels, HbA1c can reflect glucose excursions after a meal. HbA1c could be a better indicator of
glycometabolism disorder, because measurement errors and intra-individual variability are
less than for fasting glucose and insulin. In addition to, current smoking and alcohol intake
were more prevalent among men than women in our study. Previous studies reported that
smoking may increase the risk of cardiovascular heart disease by promoting atherosclerosis
progression[43] suggesting that enhanced inflammation and excessive vascular remodelling
caused by smoking are contributing factors in the development of accelerated atherosclerosis
[44].
Our findings suggest that the atherosclerotic process is common in people with normal fast-
ing glucose levels, and a higher HbA1c may increase the risk of carotid atherosclerosis. Some
previous studies reported that glycemic control, as reflected by level of HbA1c, was related to
carotid IMT among people with diabetes[9].
Our study does have some limitations. First, the current study has limitation due to its cross-
sectional design. It was not possible to explain the causal relationship between HbA1c levels and
carotid atherosclerosis. Second, it may not be appropriate to generalize it to another ethnic or
age group because the study was performed with elderly Koreans. Third, as we could not con-
duct an oral glucose tolerance test, participants with diabetes or impaired fasting glucose could
be misclassified as normal. Misclassification, if any, would be expected to bias our study results
toward the null value. Thus, our study showed probably conservative results, and null findings
of the previous studies can be partially explained by this potential misclassification.
Nevertheless, our study has several distinct strengths. The study population consists of
rather homogenous and large numbered elderly people. In addition, we focused on elderly
people in a metabolically healthy condition for the purpose of investigating the association
between HbA1c and carotid IMT. As the study population was rather lean, insulin-sensitive
and had lower blood pressure and LDL levels, we can exclude the effect of these confounding
factors that can affect the progression of atherosclerosis.
Conclusions
Our study showed that increased HbA1c levels are positively related to carotid atherosclerosis
assessed by carotid IMT in an aged people with normoglycemia. Atherosclerotic risk seemed
to increase linearly according to HbA1c levels, even within normoglycemic individuals.
HbA1c level within the normal fasting glucose range may serve as a subclinical marker of
HbA1c and carotid atherosclerosis in normoglycemia
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carotid atherosclerosis in an elderly population. Fasting glucose is insufficient to verify athero-
sclerotic cardiovascular disease risk in an elderly population based on our study. Post-prandial
glucose testing is difficult to carry out, especially in an elderly population, and requires more
time and cost than a simple HbA1c test. In an elderly population, HbA1c level is a more effec-
tive and informative marker for high-risk atherosclerotic cardiovascular disease screening.
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